Webinar Basic Principles of Blood Quality Control - Hematology Version Document HORIBA Medical En
Webinar Basic Principles of Blood Quality Control - Hematology Version Document HORIBA Medical En
Table of contents
Foreword ............................................................................................................................................................ 4
1 | QUALITY CONTROL .................................................................................................................................... 4
1.1 | What is Quality Control? ..................................................................................................................... 4
1.2 | Internal Quality Control (IQC) ............................................................................................................. 4
1.3 | Externalized Internal Quality Control (eIQC) .................................................................................... 6
1.4 | External Quality Control (eQC, eQA) ................................................................................................. 7
1.5 | The control samples ............................................................................................................................ 9
2 | CALCULATIONS ........................................................................................................................................ 11
2.1 | Mean .................................................................................................................................................... 12
2.2 | XB ........................................................................................................................................................ 12
2.3 | Standard Deviation (SD).................................................................................................................... 12
2.4 | Coefficient of variation (CV) ............................................................................................................. 14
2.5 | Precision index (PI) ........................................................................................................................... 14
2.6 | Standard Deviation index (SDI) ........................................................................................................ 17
2.7 | Uncertainty ......................................................................................................................................... 21
2.8 | Sigma .................................................................................................................................................. 24
3 | LEVEY-JENNINGS AND WESTGARD RULES ......................................................................................... 27
3.1 | Levey-Jennings .................................................................................................................................. 27
3.2 | Westgard Rules .................................................................................................................................. 28
4 | DEFINITIONS ............................................................................................................................................. 30
4.1 | Repeatability ...................................................................................................................................... 30
4.2 | Reproducibility ................................................................................................................................... 30
4.3 | True value ........................................................................................................................................... 31
4.4 | Target value ........................................................................................................................................ 31
4.5 | Systematic errors .............................................................................................................................. 31
4.6 | Random errors ................................................................................................................................... 32
5 | BIBLIOGRAPHY ......................................................................................................................................... 32
5.1 | References used in this document .................................................................................................. 32
5.2 | Additional references ........................................................................................................................ 32
Foreword
This document presents the basic principles of quality control to support laboratory good practice. The aim
being to help them to develop protocols in the daily assessment of results analysis.
1 | QUALITY CONTROL
The blood analysis performed in laboratory allows, combined with observed clinical signs, to make a diagnosis
and then to be able to set up a therapeutic prescription to improve the patient health.
The quality control is a way to assess the analytical process, which also allows validation of the results of this
analysis.
It will enable the identification of possible malfunctions in the analytical process and the laboratory will then
have to find the source of these malfunctions, to implement the necessary corrective actions.
The principle is easy: the laboratory is provided with control samples which will be analyzed and compared,
either to the target values defined by the provider, or to the results obtained by other laboratories on the same
control sample’s batch.
1.2.1 | Definition
The internal quality control is performed within the laboratory with blood control samples.
Most of the time, the IQC are designed and developed by the manufacturer of the instrument/reagent, coupled
with a specific technology, often representing the best compromise between quality/specificity/stability/matrix-
effects and, sometimes, is the only control material available.
The IQC corresponds to a "continuous control" allowing the assessment of the stability of the process
through the precision of the control samples used daily in real-time.
Standard excerpt
"The laboratory shall design quality control procedures that verify the attainment of the intended quality
of results."
1.2.2 | Procedure
The laboratory will receive a control sample batch, provided by the manufacturer of the instrument or by an
independent provider, which will be analyzed daily, morning and evening time as a minimum, to frame the
routine analysis (depending on the laboratory policy).
It's highly recommended to run at least two samples levels at minimum (high and low), to frame the measuring
field of the laboratory.
Note:
- the shutdown of the instrument processed at the end of the day corresponds to a maintenance action which can have an impact
on the analytical process. It's therefore necessary to run the controls before to validate the results of the day and to close the
session.
- in case of incorrect results, all the analysis from the previous control will have to be assessed and could have to be repeated
(after possible corrective measures and a valid control).
Standard excerpt
"The laboratory shall have a procedure to prevent the release of patient results in the event of quality
control failure."
1.2.3 | Utility
The IQC is used for:
- ensuring the follow-up of the analytical system by a surveillance of the control results over time and to
detect any analytical issue.
- to assess if the precision of the results is constant from a day/month to another (CV of the
laboratory).
- to assess the IQC results and then validate the daily series of patient results.
1.3.1 | Definition
This is a comparison of IQC processed by several laboratories on the same control sample batch, including
comparison of the mean, generally over a monthly period, allowing the estimate of precision and trueness
(bias).
Note:
- for more details on precision, see chapter "2.5 Precision Index (PI)".
- for more details on trueness, see chapter "2.6 Standard Deviation Index (SDI)".
- the IQC does not have to be related to an External Quality Control (EQC).
It generally means routine control samples used for the IQC (continuous control of precision), from which the
monthly mean results are externalized to be compared to a peer group.
The comparison to the peer group's mean as a reference value can be more relevant than the target values of
the provider. The laboratory can use this externalization to assess the trueness of the method.
Note: For more details on the true value, see chapter "4.Definitions".
The peers correspond to all the laboratories contributing to the same quality control program. They are divided
into homogenous groups (same instrument type, same control sample batch, same technology or same
instrument manufacturer), which are called "peer groups" (considering that there needs to be a minimum
between 6 and 10 instruments to establish a peer group).
Note: the peer group segmentation can vary according the quality control providers.
1.3.2 | Procedure
This is the same as the IQC procedure (see previous chapter), except for the externalization of the data
required for the comparison to the peer group.
QCP Benefits
HORIBA Medical provides an externalized internal quality control program (eIQC): the QCP.
Peers represent the laboratories all over the world who possess HORIBA Medical’s instrumentation
and contribute to this program.
Each peer group represents an homogenous group using the same type of instrument and the same
control sample batch.
Note: The laboratory will have to send their results to the QCP website (manually or automatically).
The final QCP reports will be then sent to each participant between the 15 th and the 18th of the month for the results of the
previous one.
Every month the laboratory will send the mean of their results for each parameter, which will then allow them
to receive the eIQC results (comparing their results to the peer group ones).
The comparison will be carried out between the mean of several runs of several sample tubes of the
laboratory (for a same level, a same batch and over a specific period), with the mean of the multiples runs
performed by the laboratories of the peer group.
QCP Benefits
With the QCP, the laboratories are able to compare their results at any time with the laboratories of
the peer group. In addition, it is possible to download some intermediary reports throughout the
duration of the control, without having to wait to receive the final reports which will be sent to them at
the end of the month.
This option allows them to assess their trueness, according to the data already gathered.
To do so, they will have to enter the daily results of the control sample batch, which will then allow
them to download real time reports.
The final reports will automatically be sent (15 days after the end of the month and the results
submission).
Note: There are generally enough laboratories with the same instrument configuration to get a minimum one peer group
(minimum of 6 instruments).
1.3.3 | Utility
- to assess if the results’ precision is constant from one day/month to another (CV of the laboratory)
and to compare this precision to the one of the peer group (PI).
- to measure the bias of trueness (closeness of the laboratory value with that of the peer group,
reference value defined by the mean of the multiple runs of the peer group).
Note:
- the IQC process takes into account the fact that the instrument has been correctly calibrated (at the installation, after a major
maintenance intervention, or following bad eQC results).
- The controls used in the case of an externalized IQC are the same than the ones used in the case of an IQC. The difference is
the comparison of these results with the ones of the peer group.
- see chapter 1.5.3 "Use of the target values”.
1.4.1 | Definition
The external Quality Control external Quality Assurance (eQC, eQA) represents the analytical process of a
patient sample at a specific time.
The control samples are provided by an external entity, independent of the laboratory and of the instrument
manufacturer.
Unlike the control samples of an IQC (also used for the eIQC), they will not be delivered with known target
values ("blind tests").
eQC/eQA Definition
"The external quality assessment (eQA) term is used to describe a method allowing to compare
the analysis of laboratories to an external reference […]. This comparison may be lead to compare
the performances of a group of similar laboratories.
The eQA term is sometimes used interchangeably with the "Proficiency Testing" term […].
The eQA is defined as a system allowing to objectively assess the performances of the
laboratories […]."
Note: an externalized ICQ does not exempt from the use of an EQC, but it becomes mandatory when no EQC exists for the considered
method.
1.4.2 | Procedure
When a laboratory subscribes to an external Quality Control, it will receive one or several control samples.
Each of these control samples is processed singly on only one run per cycle / event of the program
(corresponding to a month or a quarter, dependent on the provider).
Standard Excerpt
"The laboratory shall participate to an interlaboratory comparison program(s) (such as an external quality
assessment program or proficiency testing program) appropriate to the examination and interpretations
of examination results".
The results will be then be sent to the eQA provider, and these results will be compared to the mean of the
peer group's runs.
The comparison will be made between the unique run of a unique tube in the laboratory and the mean of the
unique runs obtained by each laboratory of the peer group.
The laboratory will receive a report at the end of the analysis period (cycle / event, for example a cycle can
correspond to one month, a quarter or a semester, dependent on the eQC providers).
1.4.3 | Utility
The eQC is used to measure the accuracy of the bias (comparison of the results of the laboratory with the
ones of the peer group).
Note: the trueness and the accuracy are very close notions. For more details on their differences, please refer to the chapter 2.6 "Standard
Deviation Index (SDI)").
1.5.1 | Definition
As a full blood count control sample consists of biological material which is limited by the stability of its
components over time, manufacturers are stabilizing them with chemical treatments. Even so, it can
nevertheless be possible to observe a small variation of the MCV over time (ageing of the control which must
be known and documented in order to control the variation).
These samples can be subjected to a wide range of temperature and mechanical agitation, which could
damage the cells and, therefore, the strict respect of their open stability and the number of planned runs is
crucial.
It means that the blood is specifically designed for a specific quality control program.
Most of the control samples are available in three different levels of concentration:
- low,
- normal,
- high.
HORIBA Medical provides several types of controls for hematology (synthetic bloods):
- ABX Minotrol 16: for the control of instruments with a screening leukocyte differential (3 Diff).
- ABX Difftrol: for the control of instruments with a complete leukocyte differential (5 Diff and 5Diff +
nRBC for the Yumizen H1500/2500).
- Erytrol: for the control of instruments with a separate nRBC (Erythroblast) counting (only for the Nexus
instruments).
- ABX Minotrol Retic: for the control of instruments with reticulocyte counting.
- ABX Minotrol CRP: for the control of the instruments with a screening differential (3 Diff) combined
with C-reactive protein (CRP).
Note: the control samples are considered stable, but if assessment of the instrument and of the human process (pre and post analytic)
has not led to determine the origins of any issues of a non-correct result, it is then recommended to question their stability).
1.5.2 | Reminder of the procedure for the use of HORIBA Medical control samples:
1. Remove the control from the refrigerator and allow it to reach ambient temperature for 10 minutes.
Roll the tubes between the palms for 30 seconds. Do not shake.
2. Refer to the user manual to enter the control on the instrument (manually or via the bar-code scanner).
3. Gently invert the tube 8 to 10 times (180° rotation) immediately before sampling on the instrument
4. Verify the control results according to the procedure described in the user manual.
5. After use, wipe the threads of the sample tube and tube cap with lint-free gauze.
6. Close the tube and replace it in the refrigerator immediately after use.
These actions have to be followed and standardized between all the laboratory's technicians.
Every control sample is provided with target values and confidence ranges (tolerance ranges).
Note: this only concerns the control samples provided in the frame of an IQC or an eIQC (the eQA being blindly performed).
It is highly recommended to not use these target values and confidence ranges over long term period
in the laboratory. They have to be used only at the installation of the instrument or when starting a new
IQC/eIQC batch, to be then quickly replaced by the values calculated by the laboratory itself (the mean and
the (Standard Deviation) SD obtained on their own results).
When a change of control batch occurs and before the end of the former one, the laboratory will have to run
the new and the former one in parallel during a probationary period (recommended 5 days). This is to allow
time to calculate the mean and the CV of the new batch and define the new target value of the laboratory.
Note: it is recommended to use a mobile mean to define the target value of the laboratory, it means to recalculate the mean after every
run and while the all life duration of the batch (only in hematology).
Indeed, the target values and confidence ranges are provided by the manufacturer taking into account all the
variations which can be linked to a same type of instrument (inter-instruments variations).
It is therefore highly recommended for the laboratory to define their own target values and confidence ranges
to take into account the variations of the instrument they are using (intra-instrument variations).
Note: The confidence ranges, communicated by the provider are specific to the control samples. A value initially found inside these
confidence ranges ensure that the control has not been altered before his first use.
How to define your target value (mean recalculated by the laboratory) and your limits (SD)? :
1. Analyze the control sample 10 to 20 times (over at least 5 days, either 4 runs/day over 5 days
minimum).
2. Calculate the mean of these runs for each parameter.
3. This mean has to be between the confidence ranges indicated by the provider.
4. The mean calculated corresponds to the new target value or reference value of the laboratory for the
new control batch.
5. Use the standard deviation previously determined in the laboratory via previous control batches or the
one from the last QCP report (for the same control sample level).
6. Following the process of these 10/20 runs, it is then possible to establish a new mean (target value).
7. Generally, the acceptable limits are established at 2SD or 3SD, following the quality policy of the
laboratory.
2 SD: 95% of the results are expected to be between 2SD. If a value is beyond these limits, it will
transgress the 12s rule of Westgard (see chapter "Levey-Jennings and Westgard rules" for more details).
Note: the use of the 2 SD control limits can be a risky practice, because it may generate false alarms, which could then lead to ignoring
the true ones. When a control exceeds 3 SD, it is highly likely that it is a relevant alarm, because the probability of false alarms is very
low.
3 SD: 99,7% of the results are expected between the mean 3SD. If a value is beyond these limits, it
will transgress the 13s rule of Westgard (see chapter "Levey-Jennings and Westgard rules" for more details).
Note: ideally, the quality control procedure should be chosen to minimize the false alarms and optimize the true alarms for important
analytical errors. It is also crucial that the limits of the controls are correctly set up to characterize correctly the variability observed in the
laboratory, if not, the quality control procedure will not behave as expected.
2 | CALCULATIONS
To assess the quality of the results of the control samples, different elements will be calculated:
Simple elements: directly calculated from the analysis results (from the laboratory and from the peer group
participants).
The goal of these complex elements is to compare the simple elements from the laboratory and from the peer
group.
Mean of the laboratory Nb of instruments Precision Index (PI) Uncertainty (%) Sigma (Ricos)
part of the peer
CV of the laboratory group Trueness Result +/- the Sigma (HORIBA)
(SDI or Z-score) uncertainty (#)
SD of the laboratory
Mean of the peer
group
2.1 | Mean
The mean corresponds to the best estimate of the target value of the laboratory (reference value for the
IQC) and the value for the peer group (reference value for the eIQC), of a parameter and for a specific control
level (See chapter "4.Definitions").
Mean formula
To calculate the mean of a specific control level, sum all the values gathered for this control (generally over a
one month period).
Then, divide the sum of these values by the total number of values.
Note: The mean of the peer group corresponds to the global mean of each peer group laboratory mean.
2.2 | XB
This indicator aggregates patient results (non-flagged ones) in batches of 20. The average of a batch of 20
results will be compared with the mean of previous batches to detect gaps in patient data,
all day long.
An XB alarm will be triggered if one or more means are outside the target value.
This indicator therefore allows continuous monitoring of the stability of the analytical process and is then
complementary to the framing of the series of results achieved by the use of internal controls.
Note:
- this indicator exists directly on some diagnostic instruments, but can in no way replace the use of internal controls.
- The triggering of the XB alarm will depend on the instrument settings (percentage deviation from the average, target values)
2.3.1 | Definition
The standard deviation measures the dispersion of a value’s group as a function of its mean.
2.3.2 | Explanations
Standard deviation formula
SD : Standard deviation
1. Mean: 12,43
2. Differences: (8-12,43= -4,43) ; (12-12,43= -0,43) ; (13-12,43= 0,57) ; (16-12,43= 3,57) ; (7-12,43= -5,43) ;
(13-12,43= 0,57) ; (18-12,43= 5,57)
3. Squares: (-4,43)²=19,02 ; (-0,43)²=0,18 ; (0,57)²=0,32 ; (3,57)²=12,7 ; (-5,43)²=29,5 ; (0,57)²=0,32 ; (5,57)² = 31,02
4. Sum: 93,66
5. Division: 15,61
6. Square root: 3,9
2.3.3 | Interpretation
+/- 2 SD
+/- 1 SD
(Mean)
If the studied statistical series follows a normal law, we will get the following repartition:
- 1 SD: 68,2% of the elements/results of the statistical series are between ( − σ) and ( + σ).
- 2 SD: 95% of the elements/results of the statistical series are between ( − 2σ) and ( + 2σ).
- 3 SD: and 99,6% of the elements/results of the statistical series are between ( − 3σ) and ( + 3σ).
- 4 SD: and 99,8% of the elements/results of the statistical series are between ( − 4σ) and ( + 4σ).
(where represents the mean of the series and a sigma (σ) = 1 SD).
The further the elements/results of the series are from the mean, the higher the standard deviation (and the
instrument results are less homogenous).
If the value of a standard deviation (+/- 1 SD) increases over time, it means that it will need to move more
away from the mean to encompass 68,2% of the series results.
2.4.1 | Definition
The coefficient of variation also represents the spread of the measures around the mean and assesses the
precision of the instrument:
The precision refers to the reproducibility of the analyses and the measure of the
closeness of the different results of a same sample.
This indicator only assesses the precision of the results of several runs and not
whether these results are true or accurate.
2.4.2 | Explanations
The coefficient of variation corresponds to the ratio of the standard deviation to the mean and is expressed as
a percentage:
2.4.3 | Interpretation
The lower the value of the CV, the higher the precision of the instrument. Indeed, it will mean that the different
results will be framed in a more contained space around the mean.
These statistics allows the pathologist to more easily compare the global precision of the results and therefore
the stability of the analytical process.
The standard deviation generally increases along with the concentration of the parameter, but the CV
can be considered as a statistical moderator.
If the pathologist or technicians try to compare the precision of two different methods and overall two different
levels and are only using the standard deviation, this can easily mislead them.
2.5.1 | Definition
The goal of the Precision Index is to compare the precision of the laboratory with the mean of the peer group.
2.5.2 | Explanations
As the precision is measured by the Coefficient of Variation (CV), the precision Index simply divides the CV of
the laboratory by the CV of the peer group.
The result will then indicate if the analyses of the laboratory are as reproducible as the ones performed by the
peer group.
Precision formula
2.5.3 | Interpretation
More the CV of the laboratory will be small (so better), more the value of the PI will be small too.
The blue bars indicate the precision (ratio of the CV of the laboratory and the CV of the peer
group).
The precision is always positive.
The value of 1 corresponds to the average CV of the peer group.
QCP Benefits
Your local QCP manager will have the possibility to be aware of the precision values which are
above 2 and to call the laboratories to provide a technical support.
If the precision is above 1, but overall above 2, here are the recommended corrective actions:
- First, check if the 3 different levels are given the same bias of trueness:
- If this is the case, it’s probably due to an instrument issue.
- If it’s not the case, it’s probably due to a tube issue. You will then have to run a new control to
confirm this hypothesis.
- It is necessary to study the Levey-Jennings charts, to know if the incorrect values are isolated and to
apply the Westgard rules.
- To check the data entered into the QCP.
Control samples
- Check the shipment conditions: the control sample tubes can be exposed to temperatures above the
stated ones (2°C - 8°C).
Conversely, too low a temperature could generate a lysis of the cells (low level of red blood cells and
high level of platelets, beyond the confidence ranges), leading to reject the tube from the first run.
- Check the storage conditions of the control sample (refrigerated between 2 and 8 °C).
- Check if there is progressive deterioration of the control sample (duration date).
- Check if the control sample batch has changed.
Reagents
- Check the reagents (duration date, remaining volume, storage conditions, etc…)
- Check there is no change in the reagent’s formulation.
Maintenance history
Technical
Note: this list of actions is not an exhaustive one and it's a recommendation only given for information. It is the responsibility of the
laboratory to master the corrective actions which have to be done.
2.6.1 | Definition
The Standard Deviation Index (SDI) indicates the reliability of the results, measuring the accuracy bias or the
trueness bias which corresponds to the discrepancy of the value of the laboratory compared to a reference
value (or a true value).
We are discriminating the accuracy and the trueness according to the two following definitions:
Accuracy
Gap (bias) between a unique value from the laboratory and the value from the peer
group (reference value assimilated to the true value).
Trueness
Gap (bias) between the mean of the values measured by the laboratory and a
reference value (target value provided by the controls manufacturer, target values
defined by the laboratory itself or the peer group mean).
Warning
The mean of the laboratory can get closer to the reference/true value with very
scattered values (bad precision).
The externalized eIQC and the eQC are complementary to each other.
- Indeed, the externalized IQC can be likened to a “continuous control” which allows the assessment of
precision through the CV in daily time.
It will also measure the gap (bias) to the reference value through the trueness bias (faster detection
than with an EQC).
- The eQA can be likened to a “punctual exam” which allows the assessment of the gap (bias) of a result
compared to a reference value through the accuracy bias.
- The trueness bias being calculated from a mean, it will not be impacted by the precision, which is
not the case for the accuracy bias because it is based on a unique value.
Note: the range of time between two eQA can vary according the provider (monthly, quarterly, bi-annually).
To sum up:
The results are not precise nor The precision is good: the results are The results are precise
accurate: no reproducibility. close to one another (reproducible). (reproducible), and they are
accurate/true.
But the measured values are not
accurate (far from the reference/true
value).
Note: the results cannot be accurate if they are not precise (not reproducible).
2.6.2 | Explanations
Accuracy/Trueness formula
: Standard deviation
of the peer group
The comparison of the means of the laboratory and the peer group, allows the demonstration of how far the
standard deviation of the laboratory is from the true value (peer group mean).
2.6.3 | Interpretation
The further the mean obtained by the laboratory is from the peer group mean, the greater the value of the SDI
(and the lower the accuracy of the laboratory).
The red bars indicate the trueness (the getting away from the laboratory mean compared to the peer group mean).
The trueness could be positive or negative.
The value of 0 corresponds to the peer group mean.
Note: the trueness is to put in perspective to the precision of the control level and to the clinical interest of the parameter (example: less
relevant for the parameters as MCH, MCHC and HC, which will be calculated from others parameters which already have their own
precision).
QCP Benefits
If the trueness is below -1 or above 1, a notification ( ) will appear on the report:
Your local QCP manager has the possibility to be automatically informed of the values of trueness
which are below -2 and above 2 and to call the laboratories to provide technical support.
Recommended actions:
Note:
2.7 | Uncertainty
2.7.1 | Definition
The uncertainty of the measure is composed of systematic (linked to the accuracy/trueness) and random
effects (linked to the precision).
The uncertainty is an indicator of the result quality and reliability, it is associated with every measuring result.
Example 1 Example 2
Example 1: If the measured value perfectly corresponds to the reality, the result would be equal to the real
value of the parameter.
Example 2: However, the real value of the parameter can be inside a wider area (uncertainty area of the
measuring), than the result indicated by the instrument.
This is true when we are doing a measure, whatever the parameter and whatever the technology used.
Standard excerpt
"The laboratory shall determine measurement uncertainty for each measurement procedure in the
examination phase used to report measured quantity values on patients’ samples. “
2.7.2 | Explanations
The uncertainty calculation takes into account the precision (standard deviation of the laboratory, U1(IQC)
and the one of the accuracy/trueness bias (difference between the values or mean of the laboratory and the
peer group), U2(eQA).
SD : Déviation Standard
U: Measuring uncertainty
m: Measured result
U: Uncertainty
U1 = SDlab = 0,079
Uc = √( U1² + U2²) = 0,088758
U2 = (moylab – Meangroup) / √3 = (2,54 – 2,47) / √3
= 0,07 / √3 = 0,0404 U = 2Uc = 0,177 = 0,18
U1² = 0,006241
Uc (%) = Uc / moylabo = 0,088758 / 2,54 = 3,5 %
U2² = 0,001637
QCP Benefits
The uncertainty calculation in the QCP includes an added element: the SD of the accuracy bias.
As we have seen it at the chapter "2.5.1 Definition", the accuracy can appear falsely correct.
For example, over a year, if the eQA values are equivalents, but vary between positive and negative values as
2 and -2, the accuracy bias (U2 (eQA)) can be equal to zero. However, the accuracy will not be correct at all.
Note: The greater precision of the instrument, the closer the eQA values will be to one
another and smaller the SDbias will be.
Mean of measured values
2.7.3 | Interpretation
The uncertainty of measure indicates the reliability of the measuring and is used to assess if the observed
variation really corresponds to a real analytical variation or comes from a physiological modification.
- If the uncertainty is small and that the observed variation is high, this would indicate that the variation
comes from a physiological modification.
- In the opposite, if the uncertainty of measuring is high, we should not take a variation as a pathological
variable and take inappropriate therapeutic decisions.
As the uncertainty of measuring is calculated taking into account the reproducibility (standard deviation) and
the bias, the recommended actions to improve this indicator, are the same than the ones indicated in the case
of precisions and accuracy improvements.
Note: As reminder, the comparison of the reproducibility corresponds to the precision, and the bias is involved in the accuracy calculation
and the trueness.
2.8 | Sigma
2.8.1 | Definition
The sigma is an indicator of performance which is used in the field of various activities (aviation, medical
field…).
The only difference between these sigma calculations, will be the performance thresholds which are defined
as authorized (total errors) for each measured elements.
Dr. Ricós graduated in Pharmacy at the University of Barcelona in 1969 and earned
her Doctorate in Pharmacy at the University of Barcelona in 1973. […]
Besides her normal tasks, she has been involved in establishing external quality assessment schemes
organized by the Spanish Society of Clinical Biochemistry and Molecular Pathology since 1981 and
has been chairwoman of the Analytical Quality Commission of this Society since 1990.
She has contributed to several European working groups concerning external quality assessment, and
now participates in Technical Committee 140 (Laboratory Medicine) of the European Committee for
Normalization (CEN) and in Technical Committee 212 (Clinical Laboratory and in vitro laboratory tests)
of the International Standardization Organization (ISO) working group on subjects related to External
Quality Assessment and Analytical quality Goals.
She is also a member of the Expert Advisory Panel on Health Laboratory Services, World Health
Organization (WHO) for the period 1997-2001.
She has directed two doctoral theses, and has written and lectured on a number of works related with
internal and external quality control, quality systems and quality goals. She regularly imparts classes
on laboratory accreditation, in connection with the ENAC (Spanish Accreditation Body)
In hematology, the only thresholds unanimously recognized for the different measured parameters, are the
one defined by RICOS for each parameter (calculated on mean values from literature and statistics).
2.8.2 | Explanations
Source: Clinical Chemistry Journal3
The sigma is an indicator of performance which is comparing the required performances (threshold defined
as authorized or total errors), to the actual performances of the laboratory (bias and CV) or from the peer
group (bias and CV).
We will first study the calculations to define the required performances (or total errors), the calculation of the
sigma of the laboratory, and then the calculation of the sigma of the peer group (taking into account the
technology).
- Optimal (TEo)
- Acceptable (Total Error allowable, TEa)
- Minimal (TEm)
TE : Total Error
Repro. : Reproducibility
TE = Repro. X 1,65 + Bias
Bias : Based on the intra and
inter individual variations
The 1,65 factor involve that 95% of the results will be under the limit of the total error, following a Gaussian
distribution.
These thresholds (total errors) are dependent on two different types of variations:
- Intra-individual variation: variation of the parameters for a same person over a determined period
(example: from the beginning to the end of the year).
- Inter-individual variation: variation between people (example: a smoker will have more white blood
cells than a non-smoker).
The calculations of the TEm (Minimal Total Error) and TEo (Optimal Total Error), are made following the same
way, only the coefficients used for the calculation of the reproducibility and bias are varying.
It means that the Total Error is purely statistical and which, following the inter-individual variation and the
precision of the instruments currently on the market, can either be not really relevant/achievable, or in the
opposite, too easy to achieve.
Ex : the WBC parameter has an high inter-individual variation (smoker, pregnant women, athletes…) and intra-individual (fasting,
resting,…) which mean that the statistics indicate a Tea of 15,49%.
This percentage will be too easily achievable by the existing instruments of hematology and will not represent a relevant goal.
Ex : the MCHC parameter has an inter-individual (smoker, pregnant women, athletes…) and intra-individual (fasting, resting,…) extremely
low, which involve a Tea of 1,27%.
This percentage will very hard to achieve by existing hematology instruments and also does not represent a relevant goal
In this calculation, the laboratory will be able to compare his performances (his CV and his bias) with the
statistical ones, coming from the art of state done by RICOS.
The 6 sigma is equivalent to 6 standard deviations of the laboratory sigma and is corresponding to the best
reachable performances. This indicator represents the performances to reach, but only from a physiological
and statistical point a view, and not from a technological one (it’s not taking into account the constraints and
limits of the already on the market instruments).
To solve this, HORIBA Medical also provides a sigma objective which allows the determination of the
performance of the peer group and which therefore becomes the objective to be reached, because it takes
into account the technological specificities.
Knowing that this sigma objective corresponds to the sigma of the peer group, for the bias we are comparing
the difference between the mean of the peer group and the reference value (defined by the peer group mean).
2.8.3 | Interpretation
The greater the variations between the measures in a laboratory (bad precision/reproducibility), the greater
the CV of the laboratory.
In this case, the ratio TE/CV will be low, and the performance of the laboratory considered as poor.
As the sigma is calculated taking into account the precision (CV) and the accuracy (bias), the recommended
actions to improve this indicator are the same as the ones indicated in the case of precision and accuracy
improvements.
3.1 | Levey-Jennings
3.1.1 | Definition
The Levey-Jennings chart allows the laboratory to visualize if the results of their analysis are reliable and of
good quality.
It is by means of a chart representation of the results dispersion from the mean, expressed in standard
deviation (SD).
3.2.1 | Definition
These rules are calculated to define if a measured value is considered as acceptable or not.
They give the objective means to technically validate a series.
The results are not corrects if a specific number of measured values are above a specific limit (distance to the
mean).
3.2.2 | Nomenclature
Example :
12S Rule: the results are rejected if there is ONE measured value beyond of TWO standard deviations (2SD).
3.2.2 | Logigram
To know if a series can be validated, it needs to apply the following rules to the control samples results:
Notes:
- the choice of validation or rejection of a series of results is under the responsibility of the laboratory (according to its quality
control policy). The information provided in this document is for guidance only.
- for definitions of systematic and random errors, refer to Chapter 4 "Definitions".
If the study of the detailed Levey-Jennings charts allows to show a systematic or random error, it is
recommended to put in place corrective actions (please refer to the recommended actions indicated for the
improvements of precision and accuracy).
4 | DEFINITIONS
4.1 | Repeatability
The repeatability is obtained by multiple consecutive runs of a same sample, keeping the same conditions at
every run (operator, time, reagents batches, calibration, etc…).
The repeatability is used to check that the instrument is ready to work correctly.
1. The installation
2. Before a calibration
3. Before and after a significant maintenance action (changing of spare parts, etc…).
It will allow the operator to determine the minimum CV is achieved (optimal reproducibility), and then to quickly
check the performances of the method before a calibration.
Note: a repeatability is generally done on a patient sample.
4.2 | Reproducibility
The reproducibility is obtained by the analysis of a same sample in the normal conditions of use varying the
factors as: operator, time, reagent batches, calibration, etc…).
Note: in the hematology field, according to the low stability of the blood parameters over time, a reproducibility is generally done on a
control sample.
The true value is a complicated value to achieve in hematology and there is no international standard that
can specify this value for the different parameters.
Values as close as possible to the true value are those measured by the reference methods:
- microscopy with Neubauer, Malassez or Thomas cell for counting white blood cells (WBC), red
blood cells (RBC) and platelets (PLA); selective lysis for WBC and PLA.
- photometry for the measurement of hemoglobin (HB); cyanmethemoglobin complex method and lysis
with cyanide.
- measurement of the volume of red blood cells in relation to the total volume of blood after
centrifugation for the measurement of hematocrit (HT).
- microscopy with Romanowsky staining (Giemsa, Wright, MGG,...) of a blood smear for leukocyte
count.
- microscopy with supra-vital staining (B azide, blue methylene, bright blue cresyl) for counting
Reticulocytes.
Note: although microscopy can be considered as a reference method, it has a precision limit related to the number of counted cells. This
inaccuracy is all the more important when the number of cells counted is low, which creates a bias in the comparison of this count with
the so-called "true" (or assimilated to) measure. The relationship between imprecision and the number of counted cells is summarized in
the "Rumke table".
Reference values are the values to which the results will be compared without being considered as true values:
- The manufacturer’s target value corresponds to the target value provided with the control samples.
- The laboratory target value is the mean of the laboratory results for a parameter.
- The value corresponding to the mean of the peer group's results for a parameter.
Notes:
- The value of the peer group can be assimilated to the true value in the absence of a value measured from a reference method.
- The target value is the value to be achieved for each parameter and control sample level.
- Each target value is provided with confidence ranges in which 95% of the results of the control samples must be contained.
- The median can be considered as equivalent to the mean for a significant number of values.
A systematic error is detected as soon as there is a change of the control values mean. This change in the
mean can be progressive and appears as a drift or it can be sudden and appears as a real shift
- Drift: it appears as soon as there is a progressive and subtle (positive or negative) change of the
control mean.
A drift indicates a progressive loss of reliability in the analytical system.
- Shift: it appears as soon as there is a sudden change (positive or negative) in the control mean.
This indicates an important variation of the analytical performances.
Systematic error creates a bias of trueness or accuracy that can be corrected by a calibration of the
instrument.
Error that varies unpredictably, positive or negative from the calculated mean. It will be acceptable or not
depending on the defined value of the standard deviation and of the applied Westgard rules (example: a data
outside the range ± 3SD).
The random error is related to the precision of the instrument and it is difficult to make it completely disappear.
5 | BIBLIOGRAPHY
Levey S, Jennings ER. The use of control charts in the clinical laboratory. Am J Clin Pathol
1950;20:1059-66.
Shewhart WA. Economic Control of Quality of the Manufactured Product. New York:Van Nostrand,
1931.
Henry RJ, Segalove M. The running of standards in clinical chemistry and the use of the control chart.
J Clin Pathol 1952;5:305-11.
US Centers for Medicare & Medicaid Services (CMS). Medicare, Medicaid, and CLIA Programs:
Laboratory
Requirements Relating to Quality Systems and Certain Personnel Qualifications. Final Rule. Fed
Regist Jan 24 2003;16:3640-3714.
Westgard JO, Groth T, Aronsson T, Falk H, deVerdier C-H. Performance characteristics of rules for
internal quality control: probabilities for false rejection and error detection. Clin Chem 1977;23:1857-
67.
Westgard JO, Barry PL. Cost-Effective Quality Control: Managing the quality and productivity of
analytical processes. Washington DC:AACC Press, 1986.
CLSI C24-A3. Statistical Quality Control for Quantitative Measurement Procedures: Principles and
Definitions; Approved Guideline – Third Edition. Clinical Laboratory Standards Institute, Wayne, PA 2006.
CLSI H26-P2. Validation, Verification, and Quality Assurance of Automated Hematology Analyzers;
Proposed Standard—Second Edition
CLSI H38P. Calibration and Quality Control of Automated Hematology Analyzers; Proposed Standard
Tetrault GA, Steindel SJ. Daily quality control exception practices, data analysis and critique. Q-
Probes.
Northfield, IL: College of American Pathologists, 1994.
Westgard JO. Internal quality control: Planning and implementation strategies. Ann Clin Biochem
2003;40:593-611.
Westgard JO. Clinical quality vs analytical performance: What are the right targets and target values?
Accred Qual Assur 2004;10:10-14.